Results 231 to 240 of about 160,774 (316)
Supplementing Single‐Arm Trials with External Control Arms—Evaluation of German Real‐World Data
As single‐arm trials (SATs) are increasingly used in pharmaceutical research, the validity of such study designs needs to be critically assessed. We characterize the feasibility of supplementing SATs with real‐world data (RWD)‐derived external control arms by determining the proportion of SATs on breast cancer and amyotrophic lateral sclerosis (ALS ...
Martin Russek+2 more
wiley +1 more source
Sex still matters for the brain and mental health across the lifespan. [PDF]
Beltz AM, Tronson NC, Singh M, Rezq S.
europepmc +1 more source
Studies on the estrogen metabolism in human placenta
F Akasu, Hiroshi Oki, Yoko Teshima
openalex +2 more sources
Overview of a multi‐omics based drug repurposing strategy. The systematic drug repurposing strategy included the following steps: (1) osteoporosis driver signaling networks were identified from multi‐omics data; (2) drug functional modules were obtained using a network fusion approach to integrate drug similarity information; (3) all drugs were ranked ...
Dan‐Yang Liu+21 more
wiley +1 more source
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies. [PDF]
Dileo E+4 more
europepmc +1 more source
Synthesis of Azophenolcarboxylic Acids and their Estrogenic Activities. I. Synthesis.
野村 祐次郎
openalex +2 more sources
An LC–MS/MS method was developed and validated to detect 12 synthetic or endogenous hormonal growth promotants commonly utilized in the livestock industry in the United States at low pg/mg concentrations. ABSTRACT Hormonal growth promotants (HGPs) are a class of pharmaceutical agents commonly administered to cattle in the United States to improve ...
Mary Mosburg+7 more
wiley +1 more source
Exploring the effects of estrogen deficiency and aging on organismal homeostasis during menopause. [PDF]
Camon C, Garratt M, Correa SM.
europepmc +1 more source
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario Thevis+2 more
wiley +1 more source